EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Galectin‐1‐Induced Tumor Associated Macrophages Repress Antitumor Immunity in Hepatocellular Carcinoma Through Recruitment of Tregs

Xizhi Yu, Junjie Qian, Limin Ding, Caixu Pan, Xi Liu, Qinchuan Wu, Shuai Wang, Jianpeng Liu, Mingge Shang, Rong Su, Danjing Guo, Haiyang Xie und 3 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202408788 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xizhi Yu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hang…. Hauptthemen laut MEDLINE: Galectin 1, Carcinoma, Hepatocellular, Liver Neoplasms, Tumor-Associated Macrophages. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Unit Project of Chinese Academy of Medical Sciences, Research Project of Jinan Microecological Biomedicine Shandong Laboratory, Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor‐associated macrophages (TAMs) are commonly considered accomplices in tumorigenesis and tumor development. However, the precise mechanism by which tumor cells prompt TAMs to aid in evading immune surveillance remains to be further investigated. Here, it is elucidated that tumor‐secreted galectin‐1 (Gal1) conferred immunosuppressive properties to TAMs. Specifically, patient specimens and a public database is first used to analyze the clinical relevance of Gal1 in hepatocellular carcinoma (HCC). Then, it is demonstrated that TAMs functioned as a critical mediator in the Gal1‐induced progression of HCC and the establishment of an immunosuppressive tumor microenvironment. Furthermore, RNA‐sequencing determined that Gal1 promoted the upregulation of chemokine (C‐C motif) ligand 20 (CCL20) in TAMs via activating the PI3K/AKT/NF‐κB pathway. Employing an anti‐CCL20 neutralizing antibody and Foxp3DTR mice, it is demonstrated that CCR6 + Foxp3 + regulatory T cells (Tregs) recruited by Gal1‐induced TAMs contributed to reduced infiltration and dysfunctional state of CD8 + T cells, subsequently facilitating tumor progression. Targeting Gal1 dampened the secretion of CCL20 and inhibits the recruitment of Tregs, thereby activating anti‐tumor immunity and ameliorating anti‐PD‐1 resistance. Together, this findings revealed that Gal1‐induced TAMs recruited Tregs through the CCL20‐CCR6 axis. Inhibition of Gal1 improves the effectiveness of anti‐PD1 therapy, shedding important new light on the combination immunotherapy of HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Galectin 1Carcinoma, HepatocellularLiver NeoplasmsTumor-Associated MacrophagesT-Lymphocytes, RegulatoryAnimalsMiceTumor MicroenvironmentHumansMale

Stichwörter der Autor:innen

Galectin‐1hepatocellular carcinomaimmunotherapytregstumor‐associated macrophages

Substanzen

Galectin 1

Autor:innen und Institutionen

  • Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China.
  • NHC Key Laboratory of Combined Multi-organ Transplantation, Key Laboratory of Organ Transplantation, Zhejiang, 310003, China.
  • Key Laboratory of the diagnosis and treatment of organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences (2019RU019), Ha…
  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Hangzhou, 310003, China.
  • Department of Hepatobiliary and Pancreatic Surgery, Department of Liver Transplantation, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, 310000, China.

ORCID-Profile: Shusen Zheng

Förderung

  • Research Unit Project of Chinese Academy of Medical Sciences
  • Research Project of Jinan Microecological Biomedicine Shandong Laboratory
  • Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
  • National Natural Science Foundation of China

Zitieren

APA

Yu, X., Qian, J., Ding, L., Pan, C., Liu, X., Wu, Q., Wang, S., Liu, J., Shang, M., Su, R., Guo, D., Xie, H., Yin, S., Zhou, L., & Zheng, S. (2025). Galectin‐1‐Induced Tumor Associated Macrophages Repress Antitumor Immunity in Hepatocellular Carcinoma Through Recruitment of Tregs. Advanced Science. https://doi.org/10.1002/advs.202408788

Vancouver

Yu X, Qian J, Ding L, Pan C, Liu X, Wu Q, et al. Galectin‐1‐Induced Tumor Associated Macrophages Repress Antitumor Immunity in Hepatocellular Carcinoma Through Recruitment of Tregs. Advanced Science. 2025. doi:10.1002/advs.202408788

BibTeX
@article{Yu2025,
  author = {Yu, Xizhi and Qian, Junjie and Ding, Limin and Pan, Caixu and Liu, Xi and Wu, Qinchuan and Wang, Shuai and Liu, Jianpeng and Shang, Mingge and Su, Rong and Guo, Danjing and Xie, Haiyang and Yin, Shengyong and Zhou, Lin and Zheng, Shusen},
  title = {Galectin‐1‐Induced Tumor Associated Macrophages Repress Antitumor Immunity in Hepatocellular Carcinoma Through Recruitment of Tregs},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202408788}
}
Kostenlos starten →